期刊文献+

偶氮胂Ⅰ分光光度法测定替米沙坦的含量 被引量:1

Determination of the Content of Telmisartan by Spectrophotometry with Arsenazo I
原文传递
导出
摘要 在pH7.90的Britton-Robinson缓冲介质中,替米沙坦与偶氮胂Ⅰ染料反应,形成离子缔合物,溶液颜色发生明显改变,最大吸收波长在558nm,从而建立测定替米沙坦的分光光度法。在最大波长558nm处,替米沙坦浓度在0—2.25×10^(-5)mol/L时遵守比耳定律,表观摩尔吸光系数ε为3.14×10~4L/(mol·cm),检出限为5.93×10^(-7)mol/L。本法操作简便,体系稳定,灵敏度较高,选择性较好,用于临床用药和合成样中替米沙坦含量的测定,结果满意。 In Britton-Robinson of pH 7. 90 buffer medium,telmisartan reacts with arsenazo I to form an ion-association complex, the colours of solutions change obviously, the maximum absorbable wavelength is at 558nm, a sensitive spectrophotometric method is developed for determination of telmisartan. The concentration of telmisartan in the range of 0-2.25 × 10-5mol/I. obeys Beer's law at the maximum absorbable Wavelength,the apparent molar absorptivity is 3.14 × 10 4L/(mol · cm) , the detection limit is 5.93 × 10-7mol/L. The method has high sensitivity and fairly good selectivity, the method is applied to the determination of telmisartan in medicine sample and different mixture sample, with satisfactory results.
出处 《光谱实验室》 CAS CSCD 北大核心 2010年第6期2191-2196,共6页 Chinese Journal of Spectroscopy Laboratory
基金 重庆市教委科学技术项目(No.KJ101314) 重庆市涪陵区科委科技计划(No:2008-43) 重庆市高等学校优秀中青年骨干教师资助计划[渝教人(2005)2号]
关键词 分光光度法 替米沙坦 偶氮胂I Spectrophotometry Telmisartan Arsenazo I
  • 相关文献

参考文献11

  • 1Sharma A M,Hollander A,Koster J, Telmisartan in Patients with Mild/Moderate Hypertension and Chronic Kidney Disease[J]. Clin. Nephrol, 2005,63 (4) : 250-263.
  • 2Michel M C. Bohner H, Koster J et al. Safety of Telmisartan in Patients with Arterial Hypertension: An Openlabet Observational Study[J]. Drug Saf,2004,27(5):335 342.
  • 3冉兰,祝小元,张榕,雷玲.替米沙坦片的含量测定[J].华西药学杂志,2003,18(1):61-63. 被引量:15
  • 4Hempena C,Schwarz I. G.Kunz U et al. Determination of Telmisartan in Human Blood Plasma Part I:Immunoassay Development [J]. Analytica Chimica Acta , 2006,560 (1) : 35-40.
  • 5Stangier S J. Absorption, Metabolism and Excretion of Intravenously and Orally Administered [C^14] Telmisartan in Healthy Volunteers[J].J. Clim Pharmacol,2000.40(12) :1312-1322.
  • 6Xu M T,Song J F,Li N. Rapid Determination of Telmisartan in Pharmaceuticals and Serum by the Parallel Catalytic Hydrogen Wave Method[J]. Anal. Bioanal Chem..2003,377(7):1184-1189.
  • 7郑国钢,方宇瑾,方滢芝.RP-HPLC法测定替米沙坦含量及有关物质[J].药物分析杂志,2005,25(2):147-149. 被引量:6
  • 8刘世坤,刘玉兰,彭向东,邹健军,肖大伟.HPLC-MS法研究替米沙坦人体药动学和生物等效性[J].药物分析杂志,2005,25(5):519-522. 被引量:8
  • 9赵霞,许俊羽,刘文英.反相高效液相色谱法测定大鼠血浆中替米沙坦的浓度[J].中国药科大学学报,2003,34(3):247-249. 被引量:21
  • 10Li P F. Wang Y W. Wang Y et al. Determination of Telmisartan in Human Plasma by Liquid Chromatography-Tandem Mass Speetrometry[J]. Journal of Chromatography B,2005,828(1): 126-129.

二级参考文献17

  • 1Wienen W, Hauel N,Van meel JCA, et al. Pharmacological characterization of the novel nonpeptide angiotension Ⅱ receptor antagonist,BIBR-277[J]. Br J Pharmacol,1993,110:245-252.
  • 2Stangier J, Schmid J,Turk D, et al. Absorption,metabolish andexcret-Ion of int-ravenously and orally administered [ C14 ] telmisartan in healthy volunteers [J]. J Clin Pharmacol, 2000,40:1338-1346.
  • 3Mcclellan KJ, Markham A. Telmisartan[J]. Drugs, 1998,56(6):1039-1044.
  • 4Stangiet J,Su CA, Hendriks MGC, et al.The effect of telmisartan on the steady state pharmcokinetics of digoxin in healthy male volunteers[J]. J Clin Pharmacol ,2000,40(121) : 1373-1379.
  • 5Robert E,Dinnebier,PS,Herbert N,et al.Structural Characterization of Three Crystalline Modifications of Telmisartan by Single Crystal and High-Resolution X-ray Powder Diffraction[J].Journal of Pharmaceutical Sciences,2000,89(11):1465
  • 6Joachim Stangier,PhD,Chung-An P.F.Su,MD.Pharmacokinetics and safety of intravenous and oral telmisartan 20mg and 120mg in subjects with hepatic impairment compared with healthy volunteers[J].J Clin Pharmacol,2000,40:1355
  • 7Joachim Stangier,PhD,Jochen Schmid,PhD .Absorption,Metabolism,and Excretion of Intravenously and orally administered[C14]Telmisartan in healthy volunteers[J].J Clin Pharmacol,2000,40:1312
  • 8Joachim Stangier,PhD,Chung-An P.F.Su,MD. Pharmacological of Repeated Oral Doses of Amlodipine and Amlodipine Plus Telmisartan in Healthy Volunteers[J].Clin Pharmacol,2000.40:1347
  • 9McCleLlan KJ, Markham A. Telmisartan. Drugs, 1998,56 (6) : 1039.
  • 10Stangier J, Schmid J, Turck D,et al. Absorption, metabolism, and excretion of intravenously and orally administered [14C] telmisartan in healthy volunteers. J Clin Pharmacol, 2000,40 : 1312.

共引文献43

同被引文献3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部